Altre lingue PCI Biotech Holding ASA

Azioni

Tempo reale Oslo Bors Altri mercati azionari 10:34:00 11/07/2024			Variaz. 5gg	Var. 1 gen.
1,81 ^NOK	+2,26%		+1,69%	-13,60%

14/02	PCI Biotech Holding ASA riporta i risultati degli utili per l'intero anno terminato il 31 dicembre 2023	CI
2023	Pci Biotech inizia la sperimentazione sul campo della sua tecnologia proprietaria per la produzione di terapie geniche	CI

Minutes of Annual General Meeting 2024	24/05
PCI Biotech : Notice AGM 2024	03/05
PCI Biotech : Proposed resolutions for the AGM 2024	03/05
PCI Biotech Holding ASA - Notice of Annual General Meeting 2024	03/05
PCI Biotech : Annual Report 2023	02/05
PCI Biotech Holding ASA - Annual Report 2023	26/04
PCI Biotech Holding ASA Reports Earnings Results for the Full Year Ended December 31, 2023	14/02
PCI Biotech second half 2023 interim results	14/02
PCI Biotech second half 2023 interim results	14/02
PCI Biotech: Invitation to second half interim 2023 results presentation	12/02
PCI Biotech initiates field testing of its proprietary technology for gene therapy manufacturing	13/10/23
Pci Biotech Initiates Field Testing of Its Proprietary Technology for Gene Therapy Manufacturing	13/10/23
PCI Biotech: European patent for mRNA delivery with fimaNAc	07/09/23
PCI Biotech Holding ASA Announces European Patent Office Intends to Grant A New Patent Covering Delivery of mRNA	07/09/23
PCI Biotech: Employee share option scheme	04/09/23
PCI Biotech: Employee share option scheme	04/09/23
PCI Biotech: Write-down of share capital registered	01/09/23
Financial calendar	31/08/23
PCI Biotech Holding ASA Reports Earnings Results for the Second Quarter and Six Months Ended June 30, 2023	31/08/23
PCI Biotech first half 2023 interim results	31/08/23

Non ci sono risultati per questa ricerca